Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis

Anthony Rowan, Tiarnan Fallon Verbruggen, Nuala H. O'connell, Patrick J. Stapleton, Colum P. Dunne, Barry Linnane, Daryl Butler

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction. Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation. Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics. Conclusion. We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing pro-gression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.

Original languageEnglish
Article number000700.v3
JournalAccess Microbiology
Volume5
Issue number12
DOIs
Publication statusPublished - 2023
Externally publishedYes

Keywords

  • Chryseobacterium shandongense
  • cystic fibrosis
  • port-a-cath infection

Fingerprint

Dive into the research topics of 'Indwelling central venous catheter infection with Chryseobacterium shandongense – successful eradication in a 5-year-old with cystic fibrosis'. Together they form a unique fingerprint.

Cite this